Profile change history

What changed for Cibinetide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Cibinetide identity.

4Total events
4Record additions
0Version changes
3Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 4 connected records →

Showing the latest 4 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT02039687

PeptideScanner retained ClinicalTrials.gov record NCT02039687 at 2026-11-16T01:46:13.488Z. Its registry update date was 2017-04-18, and PeptideScanner's reviewed identity mapping was cibinetide.

PeptideScanner change date
November 16, 2026
Cited source date
April 18, 2017
Evidence lane
Clinical trials
Record added

ARA 290 for treatment of small fiber neuropathy in sarcoidosis.

PubMed lists PMID 24555851 in Expert opinion on investigational drugs as Journal Article, Review, with publication-date metadata of 2014-02-21 (day precision). PeptideScanner associated the retained record with the identity slug cibinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 25, 2018
Evidence lane
Literature metadata
Record added

ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception.

PubMed lists PMID 26774587 in Peptides as Journal Article, with publication-date metadata of 2016-01-13 (day precision). PeptideScanner associated the retained record with the identity slug cibinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 25, 2018
Evidence lane
Literature metadata
Record added

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

PubMed lists PMID 32674280 in Journal of clinical medicine as Journal Article, with publication-date metadata of 2020-07-14 (day precision). PeptideScanner associated the retained record with the identity slug cibinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
September 28, 2020
Evidence lane
Literature metadata